TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 7 | 7 | 16 | -7 | -4 | -35 | -3 |
| P | %wins | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/15/18 19:13 | 11/15/18 | ETON | Eton Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Maier Paul V | IL | D | P | 30 | 6.00 | 0 | 5 | 9 | 60 | D | |||||||||||||||
6/2/15 15:46 | 5/29/15 | MBVX | Mabvax Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Maier Paul V | CA | D | P | 12 | 2.30 | 0 | 5 | New | 5 | D | -77 | -79 | 4 | 167 | -28 | 2 | 0 | 3 | -1 | -5 | -3 | -30 | -60 | -78 | |
8/2/12 17:47 | 8/1/12 | SQNM | Sequenom Inc | DE | Electr | LabEq | Measuring & Controlling Devic | Maier Paul V | CA | O | CFO | P | 29 | 2.86 | 11 | 10 | 19 | 63 | I | -52 | -58 | -37 | -47 | -28 | -25 | -24 | -11 | 15 | 19 | 34 | 17 | 52 | 8 |
6/18/08 14:09 | 6/18/08 | HNAB | Hana Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Maier Paul V | CA | D | P.d | 5 | 0.7500 | 0 | 7 | New | 7 | D | |||||||||||||||
7/24/07 20:51 | 7/20/07 | ISCO | International Stem Cell Corp | Health | Drug | Pharmaceutical Preparations | Maier Paul V | CA | D | P.d | 3 | 1.70 | 0 | 2 | New | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |